Code of Federal Regulations (Last Updated: November 8, 2024) |
Title 10 - Energy |
Chapter II - Department of Energy |
SubChapter H - Assistance Regulations |
Part 603 - Technology Investment Agreements |
Subpart G - Award Terms Related to Other Administrative Matters |
Intellectual Property |
§ 603.875 - Foreign access to technology and U.S. competitiveness provisions.
-
§ 603.875 Foreign access to technology and U.S. competitiveness provisions.
(a) Consistent with the objective of enhancing national security and United States competitiveness by increasing the public's reliance on the United States commercial technology, the contracting officer must include provisions in a TIA that addresses foreign access to technology developed under the TIA.
(b) A provision must provide, as a minimum, that any transfer of the technology must be consistent with the U.S. export laws, regulations and the Department of Commerce Export Regulation at Chapter VII, Subchapter C, Title 15 of the CFR (15 CFR parts 730-774), as applicable.
(c) A provision should also provide that any products embodying, or produced through the use of, any created intellectual property, will be manufactured substantially in the United States, and that any transfer of the right to use or sell the products must, unless the Government grants a waiver, require that the products will be manufactured substantially in the United States. In individual cases, the contracting officer, with the approval of the program official and intellectual property counsel, may waive or modify the requirement of substantial manufacture in the United States at the time of award, or subsequent thereto, upon a showing by the recipient that:
(1) Alternative benefits are being secured for the United States taxpayer (e.g., increased domestic jobs notwithstanding foreign manufacture);
(2) Reasonable but unsuccessful efforts have been made to transfer the technology under similar terms to those likely to manufacture substantially in the United States; or
(3) Under the circumstances domestic manufacture is not commercially feasible.